Journal
NEUROCHEMISTRY INTERNATIONAL
Volume 55, Issue 4, Pages 243-252Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.neuint.2009.03.007
Keywords
Alzheimer's disease; Amyloid-beta peptide; APP mutation; Cortex; Familial AD; Postmortem human brain; Presenilin mutation
Categories
Funding
- Swedish Research Council
- Loo and Hans Osterman's Foundation
- Swedish Alzheimer Foundation
- KI Foundations
- Gun and Bertil Stohne's Foundation
- Swedish Brain Foundation
Ask authors/readers for more resources
Mutations in presenilin (PS) and amyloid precursor protein (APP) genes are a predominant cause for early-onset familial Alzheimer disease (AD). Although these mutations are rare, they have in the past decades advanced our understanding of the underlying molecular mechanisms of AD. In the present study, A beta levels were measured in cortical regions of APPsw and PSI (M146V) mutation carriers, sporadic AD (SAD) and age-matched non-demented individuals. We found similar levels of soluble A beta 42, insoluble and soluble A beta 40 in both APPsw mutation carriers and SAD. However, lower levels of insoluble A beta 42 were detected in the frontal and temporal cortex of APPsw brain. In PSI brain, insoluble A beta 40 and A beta 42 levels were significantly lower in all four cortical regions compared with SAD, whilst levels of A beta 42 were lower in frontal and occipital cortex compared with APPsw brain. The insoluble A beta 42/40 ratio was similar in SAD and APPsw but significantly higher in PSI mutation carriers. Our results indicate that the pattern of A beta deposition in PSI mutation carriers differs from that in both APPsw and SAD, whereas the pattern in APPsw mutation carriers is more similar to that in SAD. (C) 2009 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available